From: The role of microRNA-133b and its target gene FSCN1 in gastric cancer
Variables | Patients, n | |
---|---|---|
 | Total | Lower miR-133b |
 | (n =100) | (n = 57) |
Histological type | Â | Â |
 Well differentiated | 23 | 9 |
 Poorly differentiated | 77 | 48 |
Gender | Â | Â |
 male | 73 | 41 |
 female | 27 | 16 |
Age | Â | Â |
 ≥60 | 58 | 30 |
 <60 | 42 | 27 |
Venous invasion | Â | Â |
 Negative | 61 | 27 |
 Positive | 39 | 30 |
Nerve invasion | Â | Â |
 Negative | 59 | 32 |
 Positive | 41 | 25 |
Position | Â | Â |
 Cardia | 40 | 22 |
 Gastric body | 27 | 15 |
 Gastric antrum | 33 | 20 |
Borrmann typing | Â | Â |
 I | 10 | 7 |
 II | 74 | 40 |
 III | 16 | 10 |
pT stage | Â | Â |
 T1T2 | 21 | 12 |
 1T3T4 | 79 | 45 |
pN stage | Â | Â |
 N0 | 23 | 15 |
 N1N2N3 | 77 | 42 |
pM stage | Â | Â |
 M0 | 80 | 40 |
 M1 | 20 | 17 |
pTNM stage | Â | Â |
 I + II | 25 | 10 |
 III + IV | 75 | 47 |